うつ病および関連障害の治療薬としてのケタミン:進歩、可能性、および落とし穴
Diana K Orsini1,2, Sara Di Luch1,2, Gabrielle F M Lovell1,2
1Poul Hansen Family Centre for Depression, University Health Network, Toronto, ON , Canada.
Expert opinion on pharmacotherapy
|February 28, 2026
まとめ
ケタミンは精神疾患に有望であり、うつ病治療の証拠が増えています。この新しい治療法の有効性、安全性、投与経路、および潜在的な新しい用途に関する研究アップデート。
科学分野:
- 精神医学
- 薬理学
- 神経科学
背景:
- ケタミンは精神疾患の新たな治療法です。
- 最近の研究により、その治療の可能性についての理解が深まっています。
研究 の 目的:
- ケタミン研究の最近の進歩に関するナラティブレビューを提供すること。
- 新しい有効性、安全性、および投与データを要約すること。
- 潜在的な新しい適応症と課題について議論すること。
主な方法:
- 臨床試験および実世界の有効性研究のナラティブレビュー。
- 長期治療を含む安全性データの統合。
- 代替投与経路およびプロトコル最適化の分析。
主要な成果:
- ケタミンおよびエスケットアミンはうつ病に有効であるという強力な証拠があります。
- 長期使用を含む安全性データが増加しており、安心できます。
- 双極性障害、PTSD、OCDに対する有効性を示唆する予備データがあります。
結論:
- ケタミンは、さまざまな精神状態に対して大きな可能性を示しています。
- 治療プロトコルを最適化し、新しい適応症を模索するためには、さらなる研究が必要です。
- 機能的な盲検化、バイアス、およびコストが課題となります。
関連する概念動画
Electroconvulsive Therapy
1.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.6K
Parenteral Anesthetics: Overview
824
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
824
Sedatives and Hypnotics Drugs: Miscellaneous Agents
708
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
708
Drug Therapy
333
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
333
Psychosis: Goals of Pharmacotherapy
642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K


